Long-Term Effects of Nusinersen Combined Physiotherapy in Spinal Muscular Atrophy Type 1: A Case Study
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder that is characterized by generalized muscle weakness. Any study does not exist showing the results of Nusinersen and physiotherapy in SMA type 1. Our case was diagnosed with SMA type 1 at the age of 3 months. At 8 months...
Saved in:
Main Authors: | Güllü Aydın Yağcıoğlu (Author), Numan Bulut (Author), Fatma Uğur (Author), İpek Alemdaroğlu Gürbüz (Author), A. Ayşe Karaduman (Author), Öznur Yılmaz (Author) |
---|---|
Format: | Book |
Published: |
Galenos Publishing House,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the Influence of Concurrent Nutritional Therapy on Children with Spinal Muscular Atrophy Receiving Nusinersen Treatment
by: Eymen Pinar, et al.
Published: (2024) -
Nusinersen in spinal muscular atrophy: Respiratory outcomes at tertiary care centers
by: Fahad Alsohime, et al.
Published: (2020) -
Safety analysis of laboratory parameters in paediatric patients with spinal muscular atrophy treated with nusinersen
by: Xiaomei Zhu, et al.
Published: (2024) -
Quality of Life Outcomes According to Differential Nusinersen Exposure in Pediatric Spinal Muscular Atrophy
by: Meaghann S. Weaver, et al.
Published: (2021) -
Quality of Life Assessment in Romanian Patients with Spinal Muscular Atrophy Undergoing Nusinersen Treatment
by: Bogdana Cavaloiu, et al.
Published: (2024)